Prognostic Significance of Histopathological Parameters for Salivary Gland Adenoid Cystic Carcinoma

被引:7
|
作者
de Morais, Everton Freitas [1 ]
de Farias Morais, Hannah Gil [2 ]
de Almeida Freitas, Roseana [2 ]
Coletta, Ricardo D. [3 ,4 ]
机构
[1] Univ Estadual Campinas, Sch Dent, Dept Oral Diag, BR-13414018 Piracicaba, SP, Brazil
[2] Univ Fed Rio Grande do Norte, Postgrad Program Oral Sci, BR-59000000 Natal, RN, Brazil
[3] Univ Estadual Campinas, Sch Dent, Dept Oral Diag, BR-13414018 Piracicaba, SP, Brazil
[4] Univ Estadual Campinas, Sch Dent, Grad Program Oral Biol, BR-13414018 Piracicaba, SP, Brazil
基金
巴西圣保罗研究基金会;
关键词
malignant salivary gland tumors; prognosis; histopathological features; histopathological grading systems; HIGH-GRADE TRANSFORMATION; POOR-PROGNOSIS; HEAD; NECK; SURVIVAL; INVASION; METASTASIS; PREDICTORS; EXPRESSION; P53;
D O I
10.3390/dj11110262
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Adenoid cystic carcinoma (ACC) is a rare salivary gland tumor that accounts for approximately 1% of all head and neck cancers. Despite its initial indolent behavior, long-term survival is poor due to locoregional recurrence in approximately 40% and distant metastasis in up to 60% of patients who undergo radical treatment. The histological parameters of ACC and the combination of these parameters in histopathological grading systems provide valuable prognostic information about the clinical course of the disease. Within this context, this review aims to analyze the impact of histopathological parameters, individual or combined in histopathological grading systems of malignancy, on ACC prognosis. Individual histopathological parameters such as solid pattern, presence of tumor necrosis, high-grade transformation, dominance of the epithelial component, presence of perineural and lymphovascular invasion, and positive surgical margins have negative impacts on the survival of patients with ACC. There are currently four histopathological grading systems for ACC; however, few studies have validated these systems and most of them explored small cohorts with short follow-up. Considering that the application of grading systems has been associated with ACC prognosis, a broader validation will allow not only their use for prognostic prediction but also assist in treatment planning.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Salivary gland adenoid cystic carcinoma
    Thompson, Lester D. R.
    ENT-EAR NOSE & THROAT JOURNAL, 2015, 94 (07) : 262 - +
  • [2] ADENOID CYSTIC CARCINOMA OF THE SALIVARY-GLAND
    ELKON, D
    POPE, TL
    CONSTABLE, WC
    ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 1980, 106 (07) : 410 - 413
  • [3] NEW PROGNOSTIC CRITERION IN ADENOID CYSTIC CARCINOMA OF SALIVARY-GLAND ORIGIN
    SANTUCCI, M
    BONDI, R
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1989, 91 (02) : 132 - 136
  • [4] Adenoid cystic carcinoma cytology: Salivary gland and nonsalivary gland
    Chowsilpa, Sayanan
    An, Daniel
    Maleki, Zahra
    DIAGNOSTIC CYTOPATHOLOGY, 2020, 48 (12) : 1282 - 1289
  • [5] ADENOID CYSTIC CARCINOMA OF SALIVARY-GLAND ORIGIN
    MURTHY, CVR
    REDDY, CRR
    CLINICIAN, 1981, 45 (11): : 474 - 479
  • [6] Inhibition of Salidroside on Salivary Gland Adenoid Cystic Carcinoma
    LI Mei-hua1
    2.The First Hospital
    ChemicalResearchinChineseUniversities, 2010, 26 (06) : 969 - 973
  • [7] Inhibition of Salidroside on Salivary Gland Adenoid Cystic Carcinoma
    Li Mei-hua
    Zhou Hong-lan
    Wang Wei
    Qiu Xin-ru
    CHEMICAL RESEARCH IN CHINESE UNIVERSITIES, 2010, 26 (06) : 969 - 973
  • [8] Systemic therapies for salivary gland adenoid cystic carcinoma
    Sahara, Sosuke
    Herzog, Alexandra E.
    Nor, Jacques E.
    AMERICAN JOURNAL OF CANCER RESEARCH, 2021, 11 (09): : 4092 - 4110
  • [9] Cortactin overexpression in salivary gland adenoid cystic carcinoma
    Greer, RO
    Hoernig, G
    Head, JA
    Weed, SA
    MOLECULAR BIOLOGY OF THE CELL, 2002, 13 : 311A - 311A
  • [10] SALIVARY-GLAND CYLINDROMAS (ADENOID CYSTIC CARCINOMA)
    BAKIR, A
    VAILLANT, JM
    BROCHERIOU, C
    LAUDENBACH, P
    BULLETIN DU CANCER, 1974, 61 (04) : 501 - 508